Evidence map›Paper›PMID 10839817›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2000

Translational control of viral gene expression in eukaryotes.

M Gale, S L Tan, M G Katze

Open access · greenAbstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 323 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Frontiers in microbiology · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Emerging roles of tRNA-derived small RNAs in cancer biology.Experimental & molecular medicine · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

M GaleUniversity of Texas Southwestern Medical Center, Dallas, Texas, USA. mgale@mednet.swmed.edu
S L Tan
M G Katze
University of Washington · USThe University of Texas Southwestern Medical Center · US

Funding

YILMA SIV VACCINIA VACCINE TRIALP51RR000166 · NCRR · UNIVERSITY OF WASHINGTON · PI HU, SHIU-LOK · 1985 to 2011
$161.1M
TRANSLATION CONTROL OF INFLUENZA VIRUS INFECTED CELLSR01AI022646 · NIAID · UNIVERSITY OF WASHINGTON · PI KATZE, MICHAEL G · 1986 to 2009
$3.4M
HEPATITIS C VIRUS AND INTERFERON--CONTROL OF PKR BY NS5AR01AI041629 · NIAID · UNIVERSITY OF WASHINGTON · PI KATZE, MICHAEL G · 1997 to 2001
$465k
NCRR NIH HHS P51 RR000166NCRR NIH HHS RR00166NIAID NIH HHS AI22646NIAID NIH HHS AI41629NIAID NIH HHS R01 AI022646
6 · The paper itself

Abstract

As obligate intracellular parasites, viruses rely exclusively on the translational machinery of the host cell for the synthesis of viral proteins. This relationship has imposed numerous challenges on both the infecting virus and the host cell. Importantly, viruses must compete with the endogenous transcripts of the host cell for the translation of viral mRNA. Eukaryotic viruses have thus evolved diverse mechanisms to ensure translational efficiency of viral mRNA above and beyond that of cellular mRNA. Mechanisms that facilitate the efficient and selective translation of viral mRNA may be inherent in the structure of the viral nucleic acid itself and can involve the recruitment and/or modification of specific host factors. These processes serve to redirect the translation apparatus to favor viral transcripts, and they often come at the expense of the host cell. Accordingly, eukaryotic cells have developed antiviral countermeasures to target the translational machinery and disrupt protein synthesis during the course of virus infection. Not to be outdone, many viruses have answered these countermeasures with their own mechanisms to disrupt cellular antiviral pathways, thereby ensuring the uncompromised translation of virion proteins. Here we review the varied and complex translational programs employed by eukaryotic viruses. We discuss how these translational strategies have been incorporated into the virus life cycle and examine how such programming contributes to the pathogenesis of the host cell.

Indexed as

Gene Expression Regulation, ViralProtein Biosynthesis3' Untranslated RegionsAnimalsEukaryotic CellsEukaryotic Initiation Factor-2Eukaryotic Initiation Factor-4GHerpesviridaeHerpesviridae InfectionsHumansOrthomyxoviridaePeptide Initiation FactorsRibosomes3' Untranslated RegionsEukaryotic Initiation Factor-2Eukaryotic Initiation Factor-4GPeptide Initiation Factors

Identifiers

PMID10839817
PMCPMC98994
OpenAlexW2137729139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.